Welcome to the FERACCRU® website.

To help show you the right information, please choose the option that best describes you:

I am a healthcare professional

I am a patient

I am a member of the public

Adverse events should be reported to your regulatory agency. Adverse events should also be reported to either your local distributor, Norgine Limited, Norgine House, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, United Kingdom or by emailing GPharmacoVigilance@norgine.com.

Norgine B.V.
Antonio Vivaldistraat 150, 1083HP
Amsterdam, Nederland
Tel: +31 (0)20 567 09 00
Fax: +31 (0)20 567 09 99
Handelsregister: AMSTERDAM 30127007
norgine.com
© Copyright Norgine 2021.

FERACCRU is a registered trademark of the Shield group of companies, licensed to the Norgine group of companies. NORGINE and the sail logo are registered trademarks of the Norgine group of companies.

Home

Contact us

 

Cookie policy

Terms of use

Privacy policy

FERACCRU® prescribing information
FERACCRU® SmPC


GL-HAE-FER-2000058.

Date of preparation: January 2022.

External Link Disclaimer

You are now leaving a Norgine website and entering a third-party website. Norgine is not responsible for the content of external websites.

Please confirm you wish to follow this link.

Continue Cancel